Clinical Trials Logo

Clinical Trial Summary

To determine the feasibility of processes and instruments with an overarching purpose to guide the design of a larger study. To determine the feasibility of individuals with metastatic brain tumor(s) to engage in physical activity(PA) and cognitive rehabilitation (CR) as in an outpatient therapy setting.


Clinical Trial Description

Rolling recruitment for the study. Participants will be randomized into one of three treatment arms. All treatment arms will undergo physical & cognitive testing prior to whole-brain radiation therapy (WBRT)/stereotactic radiosurgery (SRS). Arm 3 will receive cognitive rehabilitation intervention sessions prior to, and concurrent with, WBRT/SRS. Approximately 14 days following WBRT/SRS: all arms will undergo physical and cognitive testing, and: Arm 1 will begin physical activity intervention. Arm 2 will begin physical activity intervention and cognitive intervention. Arm 3 will continue with cognitive intervention and begin physical activity intervention. All Arms will undergo physical and cognitive testing approximately 2.5 months post WBRT/SRS. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03096431
Study type Interventional
Source Virginia Commonwealth University
Contact
Status Terminated
Phase N/A
Start date September 1, 2017
Completion date July 9, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT05559853 - Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Completed NCT02392078 - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Recruiting NCT05288439 - A Study of How Proton Beam Radiotherapy (PBRT) Affects Brain Function and Quality of Life in Children and Young Adults Undergoing Treatment for a Brain Tumor N/A
Not yet recruiting NCT05839379 - Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting NCT05843253 - Study of Ribociclib and Everolimus in HGG and DIPG Phase 2
Not yet recruiting NCT06161974 - Study of Olutasidenib and Temozolomide in HGG Phase 2
Recruiting NCT01535430 - Assessment of Eloquent Function in Brain Tumor Patients
Recruiting NCT01908179 - Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS) N/A